Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants

Vaccine

Volumn 32, Issue S1, 2014, Pages

  Rongsen Chandola, Temsunaro ^a   Strand, Tor A ^b,c   Goyal, Nidhi ^a   Flem, Elmira ^d   Rathore, Sudeep Singh ^a   Arya, Alok ^a   Winje, Brita Askeland ^d   Lazarus, Robin ^e   Shanmugasundaram, Elango ^e   Babji, Sudhir ^e   Sommerfelt, Halvor ^d   Vainio, Kirsti ^d   Kang, Gagandeep ^e   Bhandari, Nita ^a  

^a SOCIETY FOR APPLIED STUDIES   (India)

^b INNLANDET HOSPITAL TRUST   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Encouraged breastfeeding; Immune response; Rotavirus; Vaccine; Withhold breastfeeding

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVE VACCINE; RIX4414 VACCINE; ROTAVIRUS VACCINE; VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY PRODUCTION; BLOOD; BREAST FEEDING; BREAST MILK; CHEMISTRY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOLOGY; INDIA; INFANT; MALE; PASSIVE IMMUNIZATION; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS INFECTIONS; YOUNG ADULT;

ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BREAST FEEDING; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INDIA; INFANT; MALE; MILK, HUMAN; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINE POTENCY; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 84905190311     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.078     Document Type: Article

References (35)

1. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D., et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:136-141.
2. Morris S.K., Awasthi S., Khera A., Bassani D.G., Kang G., Parashar U.D., et al. Rotavirus mortality in India: estimates based on a nationally representative survey of diarrhoeal deaths. Bull World Health Organ 2012, 90:720-727.
3. Ruiz-Palacios G.M., Guerrero M.L., Bautista-Márquez A., Ortega-Gallegos H., Tuz-Dzib F., Reyes-González L., et al. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Pediatrics 2007, 120:e253-e261.
4. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370:1757-1763.
5. Vesikari T., Itzler R., Matson D.O., Santosham M., Christie C.D., Coia M., et al. Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis 2007, 11:S29-S35.
6. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362:289-298.
7. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:606-614.
8. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.
9. Breiman R.F., Zaman K., Armah G., Sow S.O., Anh D.D., Victor J.C., et al. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. Vaccine 2012, 30:A24-A29.
10. Bhandari N., Rongsen-Chandola T., Bavdekar A., John J., Antony K., Taneja S., et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 2014, 10.1016/S0140-6736(13)62630-6.
11. Sack D., Qadri F., Svennerholm A.-M. Determinants of responses to oral vaccines in developing countries. Ann Nestle [Fr] 2008, 1-9.
12. Emmett P.M., Rogers I.S. Gastroenteritis, diarrhoea and breast feeding. Early Hum Dev 1997, 49(Suppl.):S83-S103.
13. Glass R.I., Stoll B.J., Wyatt R.G., Hoshino Y., Banu H., Kapikian A.Z., et al. Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea. Acta Paediatr Scand 1986, 75:713-718.
14. Clemens J., Rao M., Ahmed F., Ward R., Huda S., Chakraborty J., et al. Breast-feeding and the risk of life-threatening rotavirus diarrhea: prevention or postponement?. Pediatrics 1993, 92:680-685.
15. Moon S.S., Wang Y., Shane A.L., Nguyen T., Ray P., Dennehy P., et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J 2010, 29(October (10)):919-923.
16. Goveia M.G., DiNubile M.J., Dallas M.J., Heaton P.M., Kuter B.J. Efficacy of pentavalent human bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J 2008, 27:656-658.
17. Patel M., Shane A.L., Parashar U.D., Jiang B., Gentsch J.R., Glass R.I., et al. Oral rotavirus vaccines: how well will they work where they are needed most?. J Infect Dis 2009, 200:S39-S48.
18. Groome M.J., Moon S.S., Velasquez D., Jones S., Koen A., van Niekerk N., et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ 2014, 92:238-245.
19. Ward R.L., Bernstein D.I., Smith V.E., Sander D.S., Shaw A., Eiden J.J., et al. Rotavirus immunoglobulin A responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine. J Infect Dis 2004, 189:2290-2293.
20. John J., Sarkar R., Tate J.E., Flemming J., Moses P., Muliyl J., et al. Effect of supplementation with zinc and probiotics on immune responses to oral vaccines in developing countries. Presented at the Vaccines for Enteric Diseases, November 6-8, 2013 2013.
21. Ali A.S., Kazi M., Cortese M., Fleming J., Parahar U., Jiang B., et al. Impact of withholding breastfeeding around the time of vaccination on the immunogenicity of the human rotavirus vaccine in Pakistan-a randomized controlled trial. Presented at the Vaccines for Enteric Diseases, November 6-8, 2013 2013.
22. Narang A., Bose A., Pandit A.N., Dutta P., Kang G., Bhattacharya S.K., et al. Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infant. Hum Vaccine 2009, 5:414-419.
23. Bhandari N., Sharma P., Taneja S., Kumar T., Rongsen-Chandola T., Appaiahgari M.B., et al. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J Infect Dis 2009, 200:421-429.
24. Vodopija I., Baklaic Z., Vlatkovic R., Bogaerts H., Delem A., Andre F.E., et al. Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain. Vaccine 1986, 4:233-236.
25. Migasena S., Simasathien S., Samakoses R., Pitisuttitham P., Sangaroon P., van Steenis G., et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995, 13:168-174.
26. Appaiahgari M.B., Glass R., Singh S., Taneja S., Rongsen-Chandola T., Bhandari N., et al. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine 2014, 32:651-656.
27. Golding J., Emmett P.M., Rogers I.S. Gastroenteritis, diarrhoea and breast feeding. Early Hum Dev 1997, 49:S83-S103.
28. Stoll B.J. The protective effect of human milk against diarrhea. A review of studies from Bangladesh. Acta Paediatr Scand Suppl 1989, 351:131-136.
29. Blake P.A., Ramos S., MacDonald K.L., Rassi V., Gomes T.A., Ivey C., et al. Pathogen-specific risk factors and protective factors for acute diarrheal disease in urban Brazilian infants. J Infect Dis 1993, 167:627-632.
30. Staelens S., Van den Driessche M., Barclay D., Carrié-Faessler A.L., Haschke F., Verbeke K., et al. Gastric emptying in formula-fed and breast-fed infants measured with the 13C-octanoic acid breath test. J Pediatr Gastroenterol Nutr 1999, 29:46-51.
31. Cavell B. Gastric emptying in infants fed human milk or infant formula. Acta Paediatr Scand 1981, 70:639-641.
32. Billeaud C., Guillet J., Sandler B. Gastric emptying in infants with or without gastro-oesophageal reflux according to the type of milk. Eur J Clin Nutr 1990, 44:577-583.
33. Bhandari N., Mazumder S., Bahl R., Martines J., Black R.E., Bhan M.K., et al. An educational intervention to promote appropriate complementary feeding practices and physical growth in infants and young children in rural Haryana, India. J Nutr 2004, 134:2342-2348.
34. Sabetta J.R., DePetrillo P., Cipriani R.J., Smardin J., Burns L.A., Landry M.L., et al. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE 2010, 5:e11088.
35. Tavera-Mendoza L.E., White J.H. Cell defenses and the sunshine vitamin. Sci Am 2007, 297(62-65). 68-70, 72.